Drug companies accused of blocking access to cheap drugs

‘Access to cheap drugs which can prevent blindness is being blocked by pharmaceutical companies, a BMJ investigation has alleged.

Drug manufacturers are accused of attempting to derail trials which would show that a drug which costs just £65 a dose works just as well as current treatments sold to the NHS for more than ten times as much.

Age-related macular degeneration (AMD) is one of the most common eye conditions, affecting around 250,000 people in Britain.’

Read more: Drug companies accused of blocking access to cheap drugs